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ABSTRACT 24
Background -Adrenaline is the primary drug of choice for resuscitation from out-of-hospital cardiac 25 arrest (OHCA). Although adrenaline may increase the chance of achieving return of spontaneous 26 circulation (ROSC), there is limited evidence that repeated doses of adrenaline improves overall 27 survival, and increasing evidence of a detrimental effect on neurological function in survivors. This 28 paper reports the relationship between repeated doses of adrenaline and survival in a cohort of patients 29 attended by the London Ambulance Service in the United Kingdom. 30
Methods -A retrospective review of OHCA treated by the London Ambulance Service over a one 31
year period. Patients aged ≥18 years who received one or more doses of adrenaline (1 mg bolus) 32 during resuscitation were included in the analyses. Outcomes described are survival to hospital 33 discharge and survival to one year post-arrest. 34
Results -Over the one year study period, 3,151 patients received adrenaline during OHCA. A 35 significant inverse relationship was found between increasing cumulative doses of adrenaline and 36 survival both to hospital discharge and one year post-arrest. No patients survived after receiving more 37 than ten adrenaline doses. 38
Conclusion -Our study indicates that repeated doses of adrenaline are associated with decreasing 39 odds of survival. There were no survivors amongst patients requiring more than 10 doses of 40 adrenaline. 41 42 43
INTRODUCTION 45
The administration of adrenaline has been the cornerstone of treatment for out-of-hospital cardiac 46 arrest (OHCA) for decades 1 . Resuscitation guidelines worldwide recommend the use of adrenaline, 47 administered every 3-5 minutes, as part of advanced life support for cardiac arrest from all causes and 48 all rhythms 2-5 . 49
Evidence for a short-term beneficial effect of adrenaline in achieving return of spontaneous 50 circulation (ROSC) after an OHCA has been reported in several observational studies and meta-51 analyses [6] [7] [8] [9] [10] [11] . Notably, the recent randomised, double-blind PARAMEDIC2 trial, conducted within 52 ambulance services in the United Kingdom (UK), found a higher rate of ROSC, with a small increase 53 in survival to hospital discharge (<1%) 12 , something supported by two previous randomised studies 13, 54
. 55
Irrespective of any effect on survival, concern about the use of adrenaline in OHCA has been 56 growing, with accumulating evidence indicating that its use may be harmful, particularly in terms of 57 poorer neurological functioning 7, 9, 15-17 . 58 There are also questions around the quantities and numbers of doses of adrenaline given. One French 59 study reported no difference in survival between repeated administrations of high-dose (5mg) 60 adrenaline and standard-dose (1mg) adrenaline 18 , while reporting a slight increase in ROSC in the 61 high-dose group. Another study from America reported higher rates of survival with less frequent 62 administration of adrenaline than the recommended 3-5 minutes frequency of administration, 63 indirectly suggesting that larger amounts of adrenaline may have poorer outcome. 64
Our study sought to examine the relationship between repeated (1mg) doses of adrenaline and 65 survival, and explore whether there is a point during OHCA after which the administration of further 66 doses, as currently recommended, becomes futile. 67
METHODS 69

Study design 70
A retrospective, observational analysis using anonymised data from the London Ambulance Service 71 (LAS) cardiac arrest registry over a one-year period (1 st April 2012-31 st March 2013). Ethical 72 approval was not required as this study used data routinely collected for clinical audit purposes. 73
Patient population 74
All adult patients (≥18 years of age) who experienced an OHCA of presumed cardiac aetiology, and 75 received one or more doses of adrenaline (1 mg bolus) during resuscitation, were eligible for inclusion 76 in this study. 77
Study setting 78
The LAS covers the geographical area of Greater London, UK, which spans approximately 620 79 square miles and serves a population of 8.4 million people 19 . During the study period, more than 1 80 million incidents were attended by the LAS 20 , with over 10,000 of these being OHCA 21 . 81
Calls identified as 'cardiac arrest' (using the advanced Medical Priority Dispatch System) receive the 82 highest level response, with a minimum of two emergency vehicles, staffed by at least one paramedic 83 (trained in advanced life support), being dispatched to the incident. 84
All LAS clinicians operate to the Resuscitation Council (UK) guidelines 2 , which advise the 85 administration of adrenaline (intravenous or intraosseous) for all initial rhythms during an OHCA. If 86 the patient presents in ventricular fibrillation or pulseless ventricular tachycardia (VF/pVT), a 1 mg 87 bolus of adrenaline is administered after 3 unsuccessful defibrillation attempts, whereas for non-88 shockable rhythms (pulseless electrical activity (PEA) or asystole) a 1 mg bolus of adrenaline is 89 administered as soon as possible. If the cardiac arrest persists, a further dose of adrenaline is advised 90 every 3-5 minutes with no upper dose limit until either ROSC is achieved and the patient is handed 91 over to hospital, or the resuscitation attempt is terminated. If ROSC is achieved, local LAS protocol 92 allows a lower dose of adrenaline (0.1 mg bolus) to be administered to maintain the patient's blood 93 pressure and prevent re-arrest. 94
Data collection 95
Data were obtained from the LAS Out-of-Hospital Cardiac Arrest Registry that collates patient, 96
process, treatment and outcome information from multiple sources (including emergency dispatch call 97 logs, and ambulance service and hospital clinical patient records) to provide a comprehensive clinical 98 record for each OHCA. Characteristics and outcomes recorded include: patient demographics, location of arrest, presenting cardiac rhythm, bystander intervention, pre-hospital resuscitation 100 methods, ROSC and survival to hospital discharge. Long-term outcome, with survival up to 1 year 101 post-arrest, was obtained from NHS Digital Summary Care Records. 102
Data analysis 103
Data analysis and statistics were performed using Excel (Microsoft, Redmond, WA), SPSS v23 (IBM, 104
Armonk, NY) and R 3.5.1 (A Language and Environment for Statistical Computing). Statistical 105 significance was accepted when p<0.05. 106
The association between percentage survival (to hospital discharge and to one year post-arrest) and 107 independent explanatory variables was assessed using a step-wise multivariate logistic regression 108 model. We first undertook univariate logistic regressions on all known predictors of survival (age, 109 sex, adrenaline dose group, initial shockable rhythm, time from EMS call to first adrenaline dose, 110 ROSC, bystander CPR, and witness status). We then built a step-wise multivariate regression model 111 starting with the predictor that had the strongest association with the outcome based on the partial F-112 tests obtained from the regression. At each step we added the predictor that had the next strongest 113 association or excluded the predictor that no longer explained the outcome. We stopped this procedure 114 when no more predictors could be added or removed, and this is the final model upon which the 115 results are based. Collinearity between the predictors was assessed by calculating the variance 116 inflation factor (VIF) for each predictor and excluding those variables that had a VIF greater than 5. 117
No predictor met this criterion and therefore none were removed from analysis based on collinearity. 118
The number of doses of adrenaline were categorised into three categories, 1 dose, 2 doses, and >3 119 doses in the multivariate analysis. 120
When presenting results, continuous variables are presented as means ± standard deviation (SD) and 121 categorical variables are reported as counts with relative frequencies. Adjusted odds ratios (AOR) and 122 95% confidence intervals (CI) obtained from the multi-variable binomial logistic regression after 123 controlling for potential confounders were used to interpret associations between variables and 124 outcomes. 125
RESULTS 127
Resuscitation was attempted for 4,466 OHCA patients; with 3,151 (71%) meeting the criteria for 128 inclusion in the study (see Figure 1 ). In total, 137 (4.3%) patients survived to be discharged from 129 hospital, with 108 of 122 patients (88.5%; with 15 lost to follow up) still alive at one year 130 (representing 3.4% overall). Patient demographics and key event characteristics based on patient 131 outcome are summarised in Table 1 . Compared to non-survivors, those who survived to one year had 132 almost four fewer doses of adrenaline on average (p<0.001), presented with an initial shockable 133 rhythm (VF/VT) (p<0.0001), were more likely to have had a witnessed arrest (p<0.001), received a 134 higher number of shocks (p<0.001) and had an 'EMS call' to 'administration of first adrenaline dose' 135 interval that averaged five minutes faster (p<0.001). 136
Each one minute of delay from 'EMS' call to 'administration of first adrenaline dose' was associated 137 with a 7% reduction in survival (OR = 0.93; CI = 0.91, 0.96; p<0.0001) to both hospital discharge and 138 one year post arrest. However, this association was no longer significant after adjusting for other 139 covariates in the multivariate regression model (AOR = 0.98; CI = 0.95, 1.00; p=0.09). 140
Association of repeated doses of adrenaline and survival 141
The relationship between repeated adrenaline doses and survival both to hospital discharge and to one 142
year post-arrest is presented in Figure 2 and Supplementary Table 1 . The number of adrenaline doses 143 administered had a negative association with both measures of survival. Survival to hospital discharge 144 was approximately 20% with one dose of adrenaline, rapidly declining to less than 2% at five or more 145
doses. Survival to one year followed a similar pattern. There were no survivors amongst patients who 146 received more than 10 doses of adrenaline. 147
While there were variables listed in Table 1 that were significantly associated with survival at the 148 univariate level, only adrenaline dose group, presence of an initial shockable rhythm, age and sex 149 could significantly predict survival in the step-wise regression model. Therefore we present 150 association of adrenaline dose group with survival after adjusting for the significant confounders, 151 initial shockable rhythm, age and sex. 152
Multivariate analysis revealed that when adjusted for the effects of age, sex, and an initial shockable 153 rhythm, three or more doses of adrenaline were associated with an 85% decrease in the likelihood of 154 surviving to hospital discharge (AOR = 0.15; CI = 0.09, 0.26; p<0.0001) and an 82% decrease in 155 surviving to one year (AOR = 0.18; CI =0.1, 0.11; p<0.0001). Full analysis results are detailed in 156 Table 2 . 157
Two patients (out of 190; 1.1%) who received 9 doses of adrenaline, and a further 2 patients (out of 158 224; 0.9%) who received exactly 10 doses of adrenaline, survived to hospital discharge and were still alive at one year (see Supplementary Table 2 for details of these patients). The first dose of adrenaline 160 was administered to all four patients in less than 13 minutes from initiation of CPR, well within the 161 overall average (15 minutes). All cases had an end-tidal carbon dioxide (ETCO2) value over 20 162 mmHg with Cases 1 and 3 exceeding 30 mmHg. Case 2, 3 and 4 had intermittent ROSC during 163 resuscitation, with Cases 1, 2 and 3 achieving a stable ROSC which was sustained from the arrest 164 location to hospital handover. In addition, the three patients who suffered a myocardial infarction 165 (Cases 1, 2 and 4) were conveyed by ambulance directly to a specialist heart attack centre for 166 coronary intervention. 167
A total of 267 patients received more than 10 doses of adrenaline, and none survived. Using the 'rule 168 of three' 22 our study predicts that more than 10 doses of adrenaline will result in no more than 1.1% 169 (95% CI 0-1.1) of patients surviving to hospital discharge and one year post arrest. 170
171
DISCUSSION 173
This study sought to describe the association between repeated doses of adrenaline and survival. We 174 found that three or more doses were associated with a significant reduction in the odds of surviving to 175 both hospital discharge and to one year post-arrest. The decline in survival was evident up to five 176 cumulative doses of adrenaline, at which point the relationship flattened due to very few survivors, 177 with no survivors after ten doses. The significant inverse relationship between cumulative doses of 178 adrenaline and survival persisted even after adjusting for potential confounders using multivariate 179
analysis. 180
These results support the findings of Glover et al 23 who described an independent negative association 181 between the probability of survival to hospital discharge and adrenaline dose in the US and Canada. 182
We found four patients who, despite a higher number of adrenaline doses (9 or 10 doses), were still 183
alive one year post-arrest. However, it is likely that the favourable factors observed (which included a 184 reversible cause of arrest, conveyance to a specialist centre, and a short time to first adrenaline dose) 185 contributed to their survival. 186
While in our study, 'EMS call' to 'administration of first adrenaline dose' interval was not 187 significantly associated with survival after adjusting for confounders, previous studies have identified 188 a relationship between time to first dose of adrenaline and survival 24-28 in their multivariate models. demonstrated that for patients in VF/VT 27 , administration of adrenaline within 10 minutes of the 194 emergency call was associated with better one-month neurological outcome 28 . In our study, those who 195 survived to one year had an 'EMS call' to 'first adrenaline dose' time interval that was, on average, 196 five minutes faster compared to those who died. It is to be noted however, that variables used to build 197 multivariate models differed in all these studies and perhaps could explain the difference in results. 198
Being an observational study, we were unable to separate the effect of the number of adrenaline 199 doses, from the length of time a patient was in cardiac arrest and the severity of their condition, both 200 of which are known to influence outcome 29 . As such, our findings must be interpreted with caution. It 201 is likely that cumulative doses of adrenaline are a proxy for cardiac arrest duration, which is 202 associated with increasingly poor outcome, a phenomenon that has been termed 'resuscitation time 203 bias' 29 . However, given that adrenaline increases the likelihood of achieving ROSC, these two 204 variables are heavily interdependent. The observed effects may also be attributed to other unknown 205
confounders. 206
There are further limitations in the data available for our study. We were unable to obtain neurological 207 outcomes from hospitals, and this would have provided a valuable insight into the neurological effects 208 of cumulative adrenaline doses and the quality of life for OHCA survivors. Technological limitations 209 within our EMS system prevented defibrillator downloads from being available for analysis; these 210 data would have enabled us to assess the quality of CPR, something which may have impacted on 211 drug delivery and subsequent efficacy 30 . 212
Despite the limitations, our findings support the need for further research into the efficacy, timing and 213 dosage of adrenaline during resuscitation. Current guidelines recommend administration of adrenaline 214
(1 mg) every 3-5 minutes 2 ; however, in-hospital studies suggest that a less frequent dosing strategy 215 may increase survival 31 and could reduce development of secondary VF/VT 32 . One study comparing 216 high-dose adrenaline (15mg) with the standard dose (1 mg), documented an increase in ROSC and 217 survival to hospital admission with the higher dose 33 . In contrast, Frisk et al investigated a lower 218 adrenaline dose (0.5 mg), which did not affect survival to hospital discharge or favourable 219 neurological outcome for OHCA patients 34 . It is clear that the optimum dose of adrenaline is a 220 knowledge gap that needs further investigation 35 . 221
222
Conclusion 223
Our study indicates that repeated doses of adrenaline are associated with decreasing odds of 224 survival. There were no survivors amongst patients requiring more than 10 doses of adrenaline. 225 226 227
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Univariate analysis was used to compare patients who survived to 1 year and those who died. 33 cases 241
were excluded from analysis due to unknown outcomes. SD, standard deviation; CPR, 242 cardiopulmonary resuscitation; EMS, emergency medical service; VF, ventricular fibrillation; pVT, 243 pulseless ventricular tachycardia; PEA, pulseless electrical activity. 244 Table 2 . Adjusted odds ratios (AOR) for survival to hospital discharge and 1 year post-arrest. 245
Multivariate analysis was used to control for potential confounders listed on Table 1 . †An adjusted 246 odds ratio above 1.0 favors survival. SD, standard deviation; CI, confidence interval. 247
248
SUPPLEMENTARY FIGURES 249 Supplementary Table 1 . Cardiac arrest cases attended from 2012-2013 by the London Ambulance 250
Service: doses of adrenaline and return of spontaneous circulation (ROSC) sustained to hospital, 251 outcome hospital discharge and 1 year post-arrest for all initial rhythms. All percentages were 252 calculated as a percentage of total counts for each adrenaline dose. 253 Supplementary Table 2 . Case review of patients who received 9 or 10 doses of adrenaline for an out-254 of-hospital cardiac arrest and survived. M, male; CPR, cardiopulmonary resuscitation; VF, ventricular 255 fibrillation; VT, ventricular tachycardia; PEA, pulseless electrical activity; EMS, emergency medical 256 service; ROSC, return of spontaneous circulation. 257 Supplementary Table 3 . Cardiac arrest cases attended from 2012-2013 by the London Ambulance 258
Service: doses of adrenaline and outcome at 1 year post-arrest are broken down by initial rhythms. All 259 percentages were calculated as a percentage of total counts for each adrenaline dose.
